- Notation: C1C(CC2=CC=CC=C21)N
Aminoindanes are
typically divided into two main isomers: 1-
aminoindane and 2-
aminoindane. Each
isomer has
unique properties...
-
designer drug. It acts as a
selective substrate for NET and DAT.
Synthetic aminoindanes were
originally developed in the
context of anti-Parkinsonian
drugs as...
-
Sainsbury PD,
Kicman AT,
Archer RP, King LA,
Braithwaite RA (2011). "
Aminoindanes--the next wave of 'legal highs'?". Drug Test Anal. 3 (7–8): 479–482....
- 5-Iodo-2-
aminoindane (5-IAI) 5,6-Methylenedioxy-2-
aminoindane (MDAI) 5,6-Methylenedioxy-N-methyl-2-
aminoindane (MDMAI) 5-Methoxy-6-methyl-2-
aminoindane (MMAI)...
- MDAI, also
known as 5,6-methylenedioxy-2-
aminoindane, is an
entactogen drug of the 2-
aminoindane group which is
related to MDMA and
produces similar subjective...
-
Isoquinolines like perafensine, quinisocaine, and
tilisolol 2-
Aminoindanes like 2-
aminoindane, MDAI, and MMAI 2-Aminotetralins like 2-aminotetralin and MDAT...
-
number of
derivatives of 1- and 2-
aminoindane are known.
Pinterova N,
Horsley RR,
Palenicek T (2017). "Synthetic
Aminoindanes: A
Summary of
Existing Knowledge"...
- α-methyltryptamine.
Pinterova N,
Horsley RR,
Palenicek T (2017). "Synthetic
Aminoindanes: A
Summary of
Existing Knowledge".
Front Psychiatry. 8: 236. doi:10.3389/fpsyt...
- PMID 15221502.
Pinterova N,
Horsley RR,
Palenicek T (2017). "Synthetic
Aminoindanes: A
Summary of
Existing Knowledge".
Frontiers in Psychiatry. 8: 236. doi:10...
- 5,6-Methylenedioxy-N-methyl-2-
aminoindane (MDMAI), is a drug of the 2-
aminoindane group developed in the 1990s by a team led by
David E.
Nichols at Purdue...
